Structure Therapeutics CSO Lin Xichen reports disposal of common shares worth $275,830.34 - GPCR News | RalliesStructure Therapeutics CSO Lin Xichen reports disposal of common shares worth $275,830.34
G
GPCR• Structure Therapeutics CSO reports share disposal
- Structure Therapeutics Chief Scientific Officer Lin Xichen cut holdings via option exercise, ADS conversion, and sales on Sep. 1, 2026.
- Exercised options for 17,817 ordinary shares at USD 0.34 per share.
- Converted 17,817 ordinary shares into 5,939 American Depositary Shares.
- Sold 5,939 American Depositary Shares at weighted-average prices of USD 45.86 and USD 47.2.
- Ended with 228,960 ordinary shares, 0 American Depositary Shares, and options for 125,081 ordinary shares.
•
